Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial

Overview of attention for article published in Breast Cancer Research, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 52 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 31,364 followers.

Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial https://t.co/iQspf6aAD0

13 May 2021

Reply Repost Favourite

RT @LMalorni: Just published on @BCRJournal our work on the prognostic role of CTCs in patients treated with palbociclib in the TREnd trial…

25 Mar 2021

Reply Repost Favourite

RT @LMalorni: Just published on @BCRJournal our work on the prognostic role of CTCs in patients treated with palbociclib in the TREnd trial…

25 Mar 2021

Reply Repost Favourite

RT @LMalorni: Just published on @BCRJournal our work on the prognostic role of CTCs in patients treated with palbociclib in the TREnd trial…

25 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.